Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.
Open | $3.020 |
Close | $3.180 |
Volume / Avg. | 677.414K / 976.881K |
Day Range | 3.000 - 3.220 |
52 Wk Range | 1.360 - 4.450 |
Market Cap | $114.000M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 6.95% |
Days to Cover | 2.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cellectar Biosciences (NASDAQ: CLRB) through any online brokerage.
Other companies in Cellectar Biosciences’s space includes: Anixa Biosciences (NASDAQ:ANIX), Curis (NASDAQ:CRIS), FibroGen (NASDAQ:FGEN), Armata Pharmaceuticals (AMEX:ARMP) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for Cellectar Biosciences (NASDAQ: CLRB) was reported by Roth MKM on Thursday, March 28, 2024. The analyst firm set a price target for 28.00 expecting CLRB to rise to within 12 months (a possible 780.50% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $3.18 last updated May 14, 2024 at 6:58 PM EDT.
There are no upcoming dividends for Cellectar Biosciences.
Cellectar Biosciences’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Cellectar Biosciences.
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.